Roche India’s Antibody Cocktail – Casirivimib and Imdevimad – is now available as a therapy to treat patients with mild and moderate Covid at the Indraprastha Apollo Hospitals in Delhi, the hospital said in a statement on Friday.
The antibody cocktail is administered intravenously and will be administered in a specific area with well-trained healthcare staff taking into account all infection control protocols, it said, adding that cocktail must be ideally administered within 48 to 72 hours of patient testing positive for Covid-19 and before 7 days.
“This treatment has been shown to reduce the risk of hospitalization and fatality rate by 70 per cent and 71 per cent respectively and shortening the duration of symptoms by four days,” it claimed.
Uncovering the Molecular Secrets of Malaria’s Deadliest Strain: A New Research Project Malaria remains one…
Sunlight Can Cause Cancer: Prolonged exposure to sunlight and exposure to UV (ultraviolet) rays can…
https://youtu.be/mlBSCMO2NQg?si=UfC4C3WgtMZ9DhB4 Humans Are Swallowing Microplastics: A Hidden Environmental and Health Crisis In recent years, microplastics…
https://youtu.be/H_aiXVvX8Eg?si=vH4Arvq7pbpXERMF Obesity Drugs: A Comprehensive Guide to Weight Loss Solutions Obesity is one of the…
https://youtu.be/LZi8Jn0tAA8?si=bpMPudQxl1LUdgXN Cold Hands & Feet in Winter: Causes, Remedies, and Prevention Tips Winter can be…
Dysautonomia: The Silent Illness Impacting Millions of People Worldwide Dysautonomia is an umbrella term used…